WebBackground: Cyclic high-dose testosterone injections, also known as bipolar androgen therapy (BAT), is a novel treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). BAT has shown clinical activity in prior studies enrolling men with mCRPC and may potentially restore sensitivity to prior androgen receptor (AR)-targeted … WebMar 31, 2024 · Bipolar androgen therapy (BAT) is a new treatment concept for men whose prostate cancer has become resistant to standard hormone-blocking therapy. 1, 10 At first blush, the concept of using high doses of the male hormone testosterone as a …
Bipolar androgen therapy (BAT): A patient
WebDec 1, 2024 · We have previously demonstrated that the cyclical administration of supraphysiological androgen (SPA), termed bipolar androgen therapy (BAT), can result in tumor regression and clinical benefit for patients with castration-resistant prostate cancer. However, predictors and mechanisms of response and resistance have been ill defined. WebDec 2, 2024 · Abstract. Background: Previous studies with bipolar androgen therapy (BAT) have shown clinical activity in metastatic Castration Resistant Prostate Cancer (mCRPC) as well as the potential to re-sensitise prostate cancer cells to prior androgen receptor-targeted agents. None of these studies had tested BAT after chemotherapy. bimbo bread ordering
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen ...
WebApr 28, 2024 · Testosterone is the canonical growth factor of prostate cancer but can paradoxically suppress its growth when present at supraphysiological levels. We have previously demonstrated that the cyclical administration of supraphysiological androgen (SPA), entitled Bipolar Androgen Therapy (BAT), can result in tumor regression and … WebDec 17, 2012 · To evaluate the number of men treated per the bipolar androgen therapy phase of the trial who developed radiographic or clinical progression. Radiographic progression is defined using Response Evaluation Criteria In Solid Tumors Criteria … WebSep 12, 2024 · It is called bipolar androgen therapy (BAT). As the name suggests, it periodically switches from no testosterone to high testosterone, then back again, covering both bases. The theory is designed to “prevent the adaptation of prostate cancer cells to a low-androgen environment.”. [ii] In a sense, it keeps the cancer cells guessing so they ... cynthia verna watts